Florida, Lorna P.

HRN: 21-30-48  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/02/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/02/2022
05/08/2022
IVT
3g
Q6hours
S/P Tahbs, Unspecified Sepsis
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Skin & Soft TissueUnspecified SepsisMultiple Infections (tick All Sites)    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: